Prostatype Genomics AB (FRA:PGO) Days Sales Outstanding : 1,204.50 (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Prostatype Genomics AB Days Sales Outstanding?

Prostatype Genomics AB's average Accounts Receivable for the three months ended in Jun. 2023 was €0.07 Mil. Prostatype Genomics AB's Revenue for the three months ended in Jun. 2023 was €0.01 Mil. Hence, Prostatype Genomics AB's Days Sales Outstanding for the three months ended in Jun. 2023 was 1,204.50.

The historical rank and industry rank for Prostatype Genomics AB's Days Sales Outstanding or its related term are showing as below:

FRA:PGO' s Days Sales Outstanding Range Over the Past 10 Years
Min: 24.78 Med: 96.23 Max: 2774
Current: 234.52

During the past 5 years, Prostatype Genomics AB's highest Days Sales Outstanding was 2774.00. The lowest was 24.78. And the median was 96.23.

FRA:PGO's Days Sales Outstanding is ranked worse than
86.24% of 218 companies
in the Medical Diagnostics & Research industry
Industry Median: 69.44 vs FRA:PGO: 234.52

Prostatype Genomics AB's Days Sales Outstanding declined from Jun. 2022 (3,421.88) to Jun. 2023 (1,204.50).

Prostatype Genomics AB Days Sales Outstanding Historical Data

The historical data trend for Prostatype Genomics AB's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prostatype Genomics AB Days Sales Outstanding Chart

Prostatype Genomics AB Annual Data

Trend

Jun18

Jun19

Dec21

Dec22

Dec23

Days Sales Outstanding

22.81

52.14

5,110.00

176.61

98.04

Prostatype Genomics AB Quarterly Data
	Jun18	Jun19	Mar20	Jun20	Sep20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial											383.25	151.54	161.64	1,204.50	-

Competitive Comparison of Prostatype Genomics AB's Days Sales Outstanding

For the Diagnostics & Research subindustry, Prostatype Genomics AB's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Prostatype Genomics AB's Days Sales Outstanding Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Prostatype Genomics AB's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Prostatype Genomics AB's Days Sales Outstanding falls into.

Prostatype Genomics AB Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Prostatype Genomics AB's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.046	+	0.019)	/	2 )	/	0.121	*	365
=	0.0325					/	0.121	*	365
=	98.04

Prostatype Genomics AB's Days Sales Outstanding for the quarter that ended in Jun. 2023 is calculated as:

	Days Sales Outstanding (Q: Jun. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2023 )	+	Accounts Receivable (A: Jun. 2023 ))	/	count )	/	Revenue (A: Jun. 2023 )	*	Days in Period
=	( (0.078	+	0.054)	/	2 )	/	0.005	*	365 / 4
=	0.066					/	0.005	*	365 / 4
=	1,204.50

Prostatype Genomics AB (FRA:PGO) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Prostatype Genomics AB Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Prostatype Genomics AB's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Prostatype Genomics AB (FRA:PGO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Prostatype Genomics AB (FRA:PGO) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

PROGEN:Sweden

Address

Gustaf III:s Boulevard 34, Solna, SWE, 169 73

Website

https://www.prostatypegenomics.com

Prostatype Genomics AB manufactures, markets and sells the prognostic gene test Prostatype. By assessing the aggressiveness of prostate cancer, Prostatype helps clinicians and patients to make correct treatment decisions. Over and under treatment of prostate cancer can be minimized, the quality of life for the patient improved and money can be saved for the health care sector.

Prostatype Genomics AB (FRA:PGO) Headlines

No Headlines